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Résumé en
anglais
Cancer is associated with venous thromboembolism in 20% of patients. In such
patients, thrombosis is difficult to treat, associated with bleeding, recurrence, and
death. Specific treatments for venous thromboembolism in cancer are
recommended. Guidelines have been implemented in many countries and
international guidelines have been recently developed. We evaluated the adhesion to
national French guidelines via a survey of cancer patients treated for venous
thromboembolism. METHODS: A national cross-sectional observational study
evaluated the adhesion to guidelines in hospitalized patients. Good clinical practice
was defined as initial 10-day treatment with injectable molecules followed by long-
term treatment with low molecular weight heparin for at least 3 months.
Demographic data, cancer type, stage, treatment, risk factors and type of
thrombosis, were recorded. RESULTS: Five patients were included in 47 centers.
Overall adhesion to guidelines was present in 59% (55-63%) of patients (295/500).
During initial treatment, adhesion was high (487/496; 98%) but dropped (296/486;
62%) during the long-term maintenance. In patients with renal insufficiency, only a
fourth of them received the adequate treatment. A majority of patients had
metastatic disease (64%). Cancer sites were gastro-intestinal (25%), gynecologic
(23%), pulmonary (21%), hematological (14%), urologic (10%), or other (8%). Lung
and hematological malignancies were significantly associated with the highest and
lowest rates of adhesion. CONCLUSION: Adhesion to national guidelines for
treatment of venous thromboembolism in cancer is not optimal. Good compliance is
observed during initial treatment, but drops after 10 days, underlying the need for
further education to achieve a better implementation on a national level.
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